Assignment of Assignor's Interest

Recorded: 2023-06-29 Pages: 9

Assignors

WANG, XING

Executed: 2022-08-16

WANG, SHAORAN

Executed: 2022-08-16

YAO, XUAN

Executed: 2022-08-16

SHI, LINYU

Executed: 2022-08-16

Assignee

HUIGENE THERAPEUTICS CO., LTD.

ROOM 1002, BUILDING #7-1, NO. 160 BASHENG ROAD, SHANGHAI, 20123, CHINA

Covered Property (1)

Engineered Crispr/CAS13 System and Uses Thereof

Application: 17/836,266 →

Publication: US 2023/0075045

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.